Oncoinvent ASA: Second half 2025 results
OSLO, Norway, Feb. 26, 2026 /PRNewswire/ -- Oncoinvent (OSE: ONCIN), a biotech company developing a receptor-independent alpha radiopharmaceutical to eradicate...
Read moreDetailsOSLO, Norway, Feb. 26, 2026 /PRNewswire/ -- Oncoinvent (OSE: ONCIN), a biotech company developing a receptor-independent alpha radiopharmaceutical to eradicate...
Read moreDetailsSINGAPORE, Feb. 26, 2026 /PRNewswire/ -- Fanstanza (https://fanstanza.gg/), a fresh, passion-driven digital publication for fans of anime, manga, games and...
Read moreDetailsResort guests can enjoy new exclusive experiences and excitement during the yearlong birthday celebrationSHANGHAI, Feb. 26, 2026 /PRNewswire/ -- Today, on...
Read moreDetailsTOKYO, Feb. 26, 2026 /PRNewswire/ -- The National Museum of Modern Art, Tokyo has launched Collection Tour "Explore with Us,"...
Read moreDetailsPhase Two: The Unprecedented Nationwide Vote Begins Today. Fans to pick their favorite name!WASHINGTON, Feb. 25, 2026 /PRNewswire/ -- In...
Read moreDetails-Poster Presentation Selected as Late Breaking Abstract-SHANGHAI and BOSTON, Feb. 25, 2026 /PRNewswire/ -- Argo Biopharmaceutical Co., Ltd. (Argo Biopharma),...
Read moreDetailsShame, alcohol, and assumptions of "low risk" drive non-disclosureSEATTLE, Feb 25, 2026 /PRNewswire/ -- A new Testing.com survey of 7,895 U.S. adults...
Read moreDetailsWUHU, China, Feb. 25, 2026 /PRNewswire/ -- In recent years, JETOUR's T Series has delivered excellent results in the light off-road...
Read moreDetailsShareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Feb. 25, 2026...
Read moreDetailsShareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Feb. 25, 2026...
Read moreDetails© 2025 World Lifestyler